MarketCap
Facebook
X
Telegram
Central Garden & Pet Company Financial Ratios 2025-2008 | CENT
Brief overview of Central Garden & Pet Company's market valuation
The comparison uses the five latest available annual observations between 2021 and 2025.
The latest available valuation ratios are P/E 13.4x (median 18.7x), EV/EBITDA 3.88x (median 7.17x), P/S 0.7x (median 0.81x). Valuation is roughly 22.6% below five-year reference levels. The discount may reflect opportunity or higher perceived risk.
At the current P/E, inverse earnings yield is 7.5%, a useful bridge between price and business earnings.
End-period return metrics are ROE 10.3%, ROA 4.5%, ROCE 15.8%. Profitability remains positive and sufficient for normal operations without indicating exceptional efficiency.
Price, earnings and growth produce a PEG of 3.09x. A high value reduces the cushion if growth slows.
The time from paying for inputs to receiving cash rose from 95.7 days to 126.4 days. Cash turnover slowed.
Valuation takeaway
Central Garden & Pet Company's multiples are below five-year reference levels despite strong quality metrics, providing valuation cushion but not eliminating hidden risks.
Annual Financial Ratios Central Garden & Pet Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
13.4 | 24.4 | 20.9 | 17.7 | 18.7 | 17.0 | 18.7 | 13.5 | 23.8 | 28.6 | 27.1 | 40.4 | -192.4 | 25.7 | 16.8 | -48.0 | 9.4 | - |
P/S |
0.7 | 0.8 | 0.8 | 0.8 | 0.9 | 0.8 | 0.7 | 0.8 | 0.9 | 0.7 | 0.5 | 0.2 | 0.2 | 0.3 | 0.3 | - | - | - |
EPS |
2.6 | 1.6 | 1.9 | 2.3 | 2.8 | 2.2 | 1.6 | 2.4 | 1.6 | 0.9 | 0.7 | 0.2 | -0.0 | 0.4 | 0.5 | -0.2 | 0.9 | - |
EV (Enterprise Value) |
1.3 B | 1.88 B | 2.14 B | 2.52 B | 2.41 B | 1.4 B | 2.26 B | 2.14 B | 2.51 B | 1.81 B | 1.44 B | 941 M | 1.04 B | 1.18 B | 1.1 B | 369 M | 537 M | -26.9 M |
EBITDA per Share |
5.31 | 4.2 | 4.56 | 5.13 | 6.11 | 4.69 | 3.52 | 4.02 | 3.96 | 3.32 | 2.52 | 1.86 | 1.52 | 2.17 | 2.01 | 2.26 | 2.23 | - |
EV/EBITDA |
3.9 | 6.8 | 7.2 | 7.4 | 7.2 | 8.7 | 9.5 | 8.8 | 11.3 | 9.3 | 9.7 | 7.9 | 11.2 | 9.0 | 7.9 | 2.7 | 3.5 | - |
PEG |
3.09 | 4.29 | 4.38 | 2.42 | 1.3 | 1.16 | -0.61 | 0.28 | 0.3 | 0.81 | 0.1 | 0.07 | 1.76 | -2.08 | -0.58 | - | - | - |
P/B |
0.6 | 0.7 | 0.8 | 0.8 | 0.9 | 0.9 | 1.7 | 1.8 | 2.9 | 2.3 | 1.7 | 0.7 | 0.8 | 1.2 | 1.0 | 0.4 | - | - |
P/CF |
6.6 | 6.7 | 6.9 | -79.3 | 11.3 | 7.8 | 10.0 | 21.9 | 27.0 | 10.3 | 13.2 | 3.3 | -6.8 | 11.0 | 24.5 | 3.4 | 2.8 | - |
ROE % |
10.29 | 6.94 | 8.66 | 11.41 | 12.40 | 11.20 | 9.32 | 12.98 | 12.37 | 8.05 | 6.33 | 1.82 | -0.41 | 4.57 | 6.20 | -1.81 | 12.05 | - |
ROA % |
4.49 | 3.04 | 3.72 | 4.64 | 4.87 | 5.16 | 4.58 | 6.48 | 6.03 | 3.77 | 2.83 | 0.77 | -0.16 | 1.84 | 2.59 | -0.85 | - | - |
ROCE % |
15.79 | 11.92 | 14.51 | 19.50 | 20.80 | 18.37 | 8.71 | 9.88 | 14.37 | 13.22 | 9.58 | 5.76 | 4.11 | 7.89 | 9.46 | 20.55 | 23.02 | - |
Current Ratio |
- | - | - | - | - | - | 4.7 | 5.7 | 3.1 | 3.4 | 3.7 | 3.9 | 3.7 | 3.2 | 3.1 | - | - | - |
DSO |
38.0 | 37.6 | 39.1 | 41.7 | 42.9 | 46.8 | 46.0 | 45.5 | 42.3 | 40.1 | 45.9 | 44.1 | 42.9 | 43.5 | 43.8 | - | - | - |
DIO |
126.7 | 129.1 | 137.2 | 126.3 | 88.0 | 87.1 | 101.3 | 101.4 | 98.1 | 103.6 | 105.5 | 103.6 | 120.2 | 101.6 | 106.0 | 51.7 | - | - |
DPO |
38.3 | 32.6 | 31.4 | 35.9 | 35.3 | 34.1 | 32.4 | 26.1 | 26.5 | 29.3 | 27.9 | 28.1 | 31.8 | 39.0 | 37.5 | 20.4 | - | - |
Operating Cycle |
164.7 | 166.7 | 176.3 | 167.9 | 130.9 | 133.9 | 147.3 | 146.9 | 140.4 | 143.7 | 151.3 | 147.6 | 163.1 | 145.0 | 149.8 | 51.8 | - | - |
Cash Conversion Cycle |
126.4 | 134.0 | 144.9 | 132.1 | 95.7 | 99.8 | 114.9 | 120.7 | 113.8 | 114.4 | 123.4 | 119.6 | 131.3 | 106.0 | 112.3 | 31.4 | - | - |
All numbers in USD currency
Quarterly Financial Ratios Central Garden & Pet Company
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
1.46 | 1.29 | 0.11 | 0.11 | 1.53 | 1.53 | 0.99 | 0.22 | 1.21 | 1.21 | 0.94 | 0.01 | 1.58 | 1.27 | -0.16 | -0.16 | - | 1.42 | 1.3 | 0.17 | - | 1.41 | 1.35 | 0.1 | 0.25 | 1.29 | 0.1 | -0.08 | 0.04 | 0.81 | -0.08 | 0.03 | 0.2 | 0.81 | 0.03 | 0.52 | 0.2 | 0.81 | 0.52 | 0.52 | 0.08 | 0.64 | 0.15 | 0.15 | -0.09 | 0.39 | -0.18 | -0.12 | -0.08 | 0.1 | 0.43 | -0.26 | -0.47 | 0.28 | 0.46 | -0.32 | -0.21 | 0.48 | 0.46 | -0.27 | -0.21 | 0.32 | 0.55 |
EBITDA per Share |
2.37 | 2.19 | 0.61 | 0.61 | 2.53 | 2.53 | 1.78 | 0.77 | 2.11 | 2.11 | 1.77 | 0.47 | 2.75 | 2.2 | 0.42 | 0.42 | - | 2.52 | 2.34 | 0.87 | - | 2.49 | 2.29 | 0.74 | 3.96 | 2.21 | 0.74 | 0.28 | 3.19 | 1.43 | 0.28 | 0.4 | 3.4 | 1.44 | 0.4 | 0.66 | 3.2 | 1.35 | 0.66 | 0.59 | 2.88 | 1.17 | 0.6 | 0.36 | 2.38 | 0.98 | 0.37 | 0.19 | 1.65 | 0.56 | 0.2 | - | 1.88 | 0.84 | - | -0.11 | 2.22 | 1.2 | -0.11 | -0.08 | 2.14 | 0.81 | -0.07 |
ROE % |
10.83 | 11.66 | 12.83 | 16.53 | 17.01 | 16.03 | 15.06 | 15.03 | 14.14 | 14.89 | 15.63 | 10.89 | 10.23 | 10.06 | 9.70 | 11.07 | 11.71 | 17.85 | 18.24 | 13.36 | 12.63 | 13.89 | 14.14 | 8.68 | 7.71 | 6.70 | 4.94 | 3.97 | 4.61 | 5.48 | 5.21 | 5.85 | 9.63 | 10.18 | 12.35 | 16.13 | 16.86 | 15.96 | 15.26 | 12.66 | 9.50 | 7.86 | 5.75 | 2.66 | -0.07 | -0.04 | -2.80 | -2.27 | -3.85 | -7.83 | -5.86 | -7.44 | -8.06 | -5.41 | -3.44 | -4.06 | -3.75 | -3.98 | -5.13 | -4.82 | -2.39 | 3.74 | -3.08 |
ROA % |
4.87 | 5.09 | 5.57 | 7.14 | 7.34 | 6.96 | 6.57 | 6.57 | 6.18 | 6.40 | 6.62 | 4.61 | 4.34 | 4.16 | 3.81 | 4.36 | 4.62 | 7.06 | 7.15 | 5.30 | 5.01 | 5.59 | 6.09 | 3.98 | 3.54 | 3.08 | 2.42 | 1.99 | 2.29 | 2.72 | 2.62 | 2.92 | 4.45 | 4.70 | 5.70 | 7.23 | 7.77 | 7.32 | 6.80 | 5.79 | 4.26 | 3.51 | 2.51 | 1.18 | 0.07 | 0.12 | -1.14 | -0.91 | -1.52 | -3.12 | -2.34 | -2.96 | -3.19 | -2.12 | -1.33 | -1.57 | -1.44 | -1.56 | -1.97 | -1.84 | -1.00 | 1.56 | -1.20 |
ROCE % |
16.21 | 17.51 | 19.11 | 24.12 | 24.91 | 23.68 | 22.45 | 22.58 | 21.31 | 22.54 | 23.76 | 17.60 | 17.06 | 17.00 | 16.77 | 18.87 | 18.84 | 27.97 | 28.09 | 22.31 | 20.18 | 36.23 | 36.81 | 30.74 | 28.47 | 26.60 | 23.79 | 21.52 | 22.37 | 23.85 | 23.32 | 24.17 | 26.51 | 33.15 | 35.88 | 38.21 | 38.38 | 37.12 | 36.72 | 36.88 | 35.08 | 31.87 | 30.87 | 29.07 | 27.55 | 21.03 | 17.11 | 15.59 | 13.53 | 16.41 | 19.63 | 17.57 | 16.48 | 20.16 | 23.69 | 22.61 | 22.86 | 24.64 | 22.09 | 22.35 | 19.65 | 8.01 | -2.66 |
DSO |
55.0 | 48.4 | 52.9 | 65.1 | 49.6 | 52.3 | 53.5 | 63.0 | 46.5 | 49.7 | 48.1 | 62.1 | 44.0 | 36.6 | 47.9 | 51.3 | - | 50.6 | 46.0 | 50.3 | - | 38.7 | 34.5 | 55.0 | 52.9 | 39.1 | 38.4 | 53.7 | 50.6 | 36.7 | 35.1 | 52.0 | 50.1 | 36.5 | 36.1 | 48.8 | 44.2 | 37.5 | 34.2 | 42.8 | 44.4 | 34.9 | 42.1 | 51.1 | 49.0 | 40.0 | 42.9 | 50.0 | 47.2 | 35.1 | 42.5 | 53.0 | 48.1 | 31.1 | 46.1 | 55.1 | 46.5 | 30.2 | 45.2 | 50.5 | 47.3 | 31.5 | - |
DIO |
114.1 | 121.7 | 178.8 | 166.2 | 104.2 | 111.9 | 133.5 | 158.5 | 105.4 | 114.1 | 136.8 | 181.6 | 112.0 | 122.3 | 205.0 | 196.4 | - | 114.1 | 118.4 | 150.7 | - | 83.5 | 86.7 | 108.5 | 28.3 | 81.0 | 120.9 | 132.7 | 33.1 | 95.8 | 136.3 | 126.7 | 33.0 | 92.2 | 128.4 | 121.0 | 32.4 | 95.9 | 128.1 | 121.0 | 33.6 | 103.0 | 129.3 | 132.0 | 34.7 | 108.2 | 143.2 | 151.1 | 33.7 | 103.9 | 172.1 | 177.4 | 39.6 | 109.4 | 178.6 | 154.1 | 33.7 | 94.0 | 161.6 | 143.3 | 35.1 | 94.7 | - |
DPO |
39.8 | 40.6 | 56.4 | 50.7 | 30.6 | 34.4 | 39.5 | 40.9 | 25.7 | 28.8 | 33.0 | 41.1 | 25.7 | 25.4 | 38.9 | 41.0 | - | 34.7 | 37.0 | 48.3 | - | 30.7 | 31.8 | 45.1 | 13.2 | 33.7 | 42.9 | 43.3 | 10.6 | 31.3 | 42.3 | 34.6 | 8.5 | 25.2 | 36.5 | 33.5 | 8.8 | 26.6 | 38.2 | 36.3 | 9.5 | 30.9 | 40.4 | 38.2 | 9.2 | 31.3 | 45.2 | 45.1 | 9.1 | 31.0 | 51.8 | 48.5 | 10.5 | 29.9 | 54.3 | 54.4 | 12.9 | 33.2 | 53.5 | 49.2 | 12.4 | 32.5 | - |
Operating Cycle |
- | - | - | 231.3 | - | 164.2 | 187.1 | 221.5 | - | 163.8 | 184.9 | 243.7 | - | 158.9 | - | 247.7 | - | 164.7 | 164.5 | 201.0 | - | 122.2 | 121.3 | 163.5 | 81.2 | 120.1 | 159.3 | 186.4 | 83.7 | 132.4 | 171.4 | 178.7 | 83.1 | 128.7 | 164.6 | 169.8 | 76.6 | 133.4 | 162.3 | 163.7 | 78.0 | 137.9 | 171.4 | 183.1 | 83.7 | 148.2 | 186.1 | 201.1 | 80.9 | 139.0 | 214.6 | 230.3 | 87.7 | 140.6 | 224.8 | 209.1 | 80.2 | 124.2 | 206.8 | 193.9 | 82.4 | 126.2 | - |
Cash Conversion Cycle |
- | - | - | 180.5 | - | 129.8 | 147.5 | 180.7 | - | 135.1 | 151.9 | 202.6 | - | 133.5 | - | 206.7 | - | 130.0 | 127.5 | 152.7 | - | 91.5 | 89.5 | 118.4 | 68.0 | 86.4 | 116.3 | 143.1 | 73.1 | 101.2 | 129.1 | 144.1 | 74.6 | 103.5 | 128.0 | 136.3 | 67.9 | 106.9 | 124.0 | 127.4 | 68.5 | 107.0 | 131.1 | 144.8 | 74.5 | 116.8 | 140.9 | 155.9 | 71.8 | 108.0 | 162.8 | 181.8 | 77.2 | 110.6 | 170.4 | 154.7 | 67.3 | 91.0 | 153.4 | 144.7 | 70.0 | 93.8 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Central Garden & Pet Company, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Canada
Russia
Brasil
China
USA
Cayman-islands
